Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Department Of Defense was posted on October 4, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

MILBEMYCIN OXIME AND PRAZIQUANTEL TABLET

Awarded
SPE2DP-26-T-5196Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

Solicitation SPE2DP-26-T-5196, issued by the DLA Troop Support Medical Supply Chain, is for the procurement of one package of Milbemycin Oxime and Praziquantel chewable tablets. These chicken-flavored veterinary tablets, containing 23mg of Milbemycin Oxime and 228mg of Praziquantel, are designed for dogs 6 weeks of age and older weighing between 50.1 and 100 lbs. The product serves as a broad-spectrum parasiticide to prevent heartworm disease and treat adult roundworm, hookworm, whipworm, and tapeworm infections. Each package consists of five boxes of 12 tablets, totaling 60 tablets, and must be stored at controlled room temperature between 15-25 degrees Celsius. The requirement specifies a delivery timeframe of 89 days after receipt of order, with a required delivery date of September 22, 2026. Delivery is FOB Destination, with inspection and acceptance also occurring at the destination. Packaging must be commercial and sealed to protect contents from damage, with marking strictly adhering to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The item is subject to a non-extendable shelf life of 24 months and is regulated by the FDA. All quotes must be submitted via the DLA Internet Bid Board System by September 28, 2026, and payment processing is required through the Wide Area WorkFlow system.

General Info

DLA procurement of Milbemycin Oxime and Praziquantel tablets for dogs by September 2026.

Contract Value

$385.61

NAICS

456199 - All Other Health and Personal Care Retailers

Place of Performance

AE, USA

Set-Aside

NONE

Award Issued Date

Documents

2
PDF, High priority: read this firstaward
High
PDF, High priority: read this first18 pages · rfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Solicitation

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
Contacts1 person available
OfficeUSA
Office AddressUSA
Contacts

Full Description

Show more
DLA award SPE2DP27P0106 posted on DIBBS. Awardee: COVETRUS NORTH AMERICA, LLC (CAGE 4PG41) Total Contract Price: $385.61 Award Date: 10-04-2026 Solicitation: SPE2DP-26-T-5196 Line items: - MILBEMYCIN OXIME AND PRAZIQUANTEL TABLET (NSN/Part 6509017312313, PR 7018467850)

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS